Market diary.The markets pulled back during the week ending July 25, spooked by evidence that the fallout from the mortgage lending crisis was more widespread than initially believed. Calabasas-based Countrywide Financial Countrywide Financial Corporation (NYSE: CFC) is a diversified financial marketing and service holding company engaged primarily in residential mortgage banking and related businesses. Corp., the nation's No. 1 mortgage lender, reported in its second quarter earnings that defaults were rising even among prime mortgage borrowers. Besides sending Countrywide's stock down 12 percent, that news on July 24 sent all the major markets lower as investors feared tighter credit would hamper economic growth. After closing above 14,000 for the first time on July 19, the Dow Jones Industrial Average Dow Jones Industrial Average The best known U.S. index of stocks. A price-weighted average of 30 actively traded blue-chip stocks, primarily industrials including stocks that trade on the New York Stock Exchange. fell 1 percent to close on July 25 at 13,785.10. The Nasdaq and Standard & Poor's 500 indices fell nearly 2 percent to close at 2,648.17 and 1,518.09 respectively. The LABJ LABJ Los Angeles Business Journal index of 200 local stocks plunged 2.6 percent as 148 stocks declined and only 43 advanced. All but two of the 18 industry sectors declined, led by a 10.6 percent drop in financial services The examples and perspective in this article or section may not represent a worldwide view of the subject. Please [ improve this article] or discuss the issue on the talk page. , which saw 14 stocks hit 52-week lows. Another company wracked by the mortgage lending crisis. Fremont General Corp., was the biggest losing stock, down 29 percent to $7.39 per share. One of the few bright spots was Cougar cougar: see puma. cougar or puma or mountain lion or panther Species (Puma concolor) of large, graceful cat that lives in a wide variety of habitats in the Americas, from southern Alaska to Patagonia. Biotechnology Inc., whose stock soared 10 percent after the company received permission from the U.S. Food and Drug Administration to proceed with clinical trials for a cancer treatment drug. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion